Will a urine benzodiazepine screen be positive in a patient who is only taking Kadian (extended‑release morphine) and methadone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No, benzodiazepine screens will be negative in patients taking only Kadian (morphine) and methadone

A patient taking only Kadian (extended-release morphine) and methadone should not test positive for benzodiazepines on urine drug screening, as these are opioid medications that do not cross-react with benzodiazepine immunoassays.

Why Opioids Don't Trigger Benzodiazepine Screens

Benzodiazepine immunoassays are designed to detect benzodiazepines and their metabolites (typically oxazepam as the common metabolite) 1. These tests are class-specific and do not cross-react with opioid medications like morphine (Kadian) or methadone 2, 3.

  • Morphine (the active ingredient in Kadian) will only trigger opioid/opiate immunoassays 4, 3
  • Methadone requires its own specific immunoassay and will not be detected on standard opiate screens 2, 3
  • Neither medication has chemical structures that would cause cross-reactivity with benzodiazepine tests

Important Caveats About Benzodiazepine Testing

False-Positive Triggers (Not from Opioids)

While opioids won't cause false-positive benzodiazepine results, other medications can 5:

  • Sertraline
  • Oxaprozin (NSAID)
  • Certain antihistamines

False-Negative Benzodiazepine Results

Standard benzodiazepine immunoassays may miss certain benzodiazepines even when they are present 1, 2:

  • Clonazepam is not metabolized through the oxazepam pathway and is commonly missed 1
  • Alprazolam may not be detected by some immunoassays 2
  • Designer benzodiazepines (flualprazolam, flubromazolam, etizolam) are frequently undetected by standard panels 6

Clinical Interpretation

If a patient on only Kadian and methadone shows a positive benzodiazepine screen:

  1. Suspect undisclosed benzodiazepine use (prescribed or illicit)
  2. Review all medications for potential cross-reactants 5
  3. Confirm with GC-MS or LC-MS-MS to identify the specific substance 1, 2
  4. Consider designer benzodiazepines if confirmatory testing is negative for standard benzodiazepines 6

If the screen is negative for benzodiazepines in this patient, this is the expected result and confirms no benzodiazepine exposure (within the limitations of the test's detection window and sensitivity to specific benzodiazepines).

What You Should Expect on UDS

A patient taking only Kadian and methadone should show:

  • Positive for opiates/morphine (from Kadian) 3
  • Positive for methadone (if methadone-specific immunoassay is ordered) 2
  • Negative for benzodiazepines (unless taking benzodiazepines separately)

References

Research

Urine Drug Tests: Ordering and Interpreting Results.

American family physician, 2019

Research

Urine drug screening: a valuable office procedure.

American family physician, 2010

Research

Commonly prescribed medications and potential false-positive urine drug screens.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.